{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:29:56Z","timestamp":1781602196947,"version":"3.54.5"},"reference-count":8,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.1001\/jamainternmed.2025.0532","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:31:16Z","timestamp":1745249476000},"page":"645","source":"Crossref","is-referenced-by-count":1,"title":["Hospital-Initiated Naltrexone for Alcohol Use Disorder"],"prefix":"10.1001","volume":"185","author":[{"given":"Melissa B.","family":"Weimer","sequence":"first","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Sections of Health Policy and Management, and Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"},{"name":"Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Sections of Health Policy and Management, and Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"},{"name":"Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"iic250005r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.0522","article-title":"Oral vs extended-release injectable naltrexone for hospitalized patients with alcohol use disorder: a randomized clinical trial.","author":"Magane","journal-title":"JAMA Intern Med"},{"issue":"1","key":"iic250005r4","doi-asserted-by":"publisher","DOI":"10.1097\/CLD.0000000000000217","article-title":"Treatment of alcohol use disorder in patients with liver disease.","volume":"23","author":"Hill","year":"2024","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"8","key":"iic250005r5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.7326\/M23-0641","article-title":"Pharmacologic treatment initiation among Medicare beneficiaries hospitalized with alcohol use disorder.","volume":"176","author":"Bernstein","year":"2023","journal-title":"Ann Intern Med"},{"issue":"2","key":"iic250005r6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/add.15572","article-title":"Effect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis.","volume":"117","author":"Murphy","year":"2022","journal-title":"Addiction"},{"issue":"3","key":"iic250005r7","doi-asserted-by":"publisher","first-page":"e243387","DOI":"10.1001\/jamanetworkopen.2024.3387","article-title":"Outcomes after initiation of medications for alcohol use disorder at hospital discharge.","volume":"7","author":"Bernstein","year":"2024","journal-title":"JAMA Netw Open"},{"key":"iic250005r2","doi-asserted-by":"crossref","unstructured":"Orgera? K, Kezh? A, Ranney? ML, Grover? A. Narrowing the gap: the burden of alcohol, drugs, and firearms on U.S. life expectancy. AAMC. Published October 2, 2024. doi:10.15766\/rai_r9oj8esu","DOI":"10.15766\/rai_r9oj8esu"},{"key":"iic250005r3","unstructured":"Healthcare Cost & Utilization Project: NEDS overview. Agency for Healthcare Research and Quality. Accessed March 19, 2025. https:\/\/hcup-us.ahrq.gov\/nedsoverview.jsp"},{"key":"iic250005r8","unstructured":"Providers Clinical Support System - medications for alcohol use disorder. PCSS. Accessed March 19, 2025. https:\/\/www.pcss-maud.org\/"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2832705\/jamainternal_weimer_2025_ic_250005_1748025397.81859.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:00:59Z","timestamp":1748876459000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2832705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2025.0532","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}